[go: up one dir, main page]

GB201918902D0 - Cell differentiation - Google Patents

Cell differentiation

Info

Publication number
GB201918902D0
GB201918902D0 GBGB1918902.6A GB201918902A GB201918902D0 GB 201918902 D0 GB201918902 D0 GB 201918902D0 GB 201918902 A GB201918902 A GB 201918902A GB 201918902 D0 GB201918902 D0 GB 201918902D0
Authority
GB
United Kingdom
Prior art keywords
cell differentiation
differentiation
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1918902.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genome Research Ltd
Original Assignee
Genome Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Research Ltd filed Critical Genome Research Ltd
Priority to GBGB1918902.6A priority Critical patent/GB201918902D0/en
Publication of GB201918902D0 publication Critical patent/GB201918902D0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/065—Thymocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
GBGB1918902.6A 2019-12-19 2019-12-19 Cell differentiation Ceased GB201918902D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1918902.6A GB201918902D0 (en) 2019-12-19 2019-12-19 Cell differentiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1918902.6A GB201918902D0 (en) 2019-12-19 2019-12-19 Cell differentiation

Publications (1)

Publication Number Publication Date
GB201918902D0 true GB201918902D0 (en) 2020-02-05

Family

ID=69322755

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1918902.6A Ceased GB201918902D0 (en) 2019-12-19 2019-12-19 Cell differentiation

Country Status (1)

Country Link
GB (1) GB201918902D0 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8440431B2 (en) 2009-12-10 2013-05-14 Regents Of The University Of Minnesota TAL effector-mediated DNA modification
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8440431B2 (en) 2009-12-10 2013-05-14 Regents Of The University Of Minnesota TAL effector-mediated DNA modification
US8440432B2 (en) 2009-12-10 2013-05-14 Regents Of The University Of Minnesota Tal effector-mediated DNA modification
US8450471B2 (en) 2009-12-10 2013-05-28 Regents Of The University Of Minnesota TAL effector-mediated DNA modification
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
D.-M. POPESCU ET AL.: "Decoding the development of the blood and immune systems during human fetal liver haematopoiesis", BIORXIV, 2019, pages 654210
FERREIRA ET AL., NATURE REVIEWS IN DRUG DISCOVERY, 2019
GREEN AND SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 2012, COLD SPRING HARBOR LABORATORY PRESS
H. HUY.-R. MIAO ET AL.: "AnimalTFDB 3.0: a comprehensive resource for annotation and prediction of animal transcription factors", NUCLEIC ACIDS RES., vol. 47, 2019, pages D33 - D38
L. HAGHVERDI ET AL.: "Diffusion pseudotime robustly reconstructs lineage branching", NAT. METHODS, vol. 13, 2016, pages 845 - 848
L. WUK. SHORTMAN: "Heterogeneity of thymic dendritic cells", SEMIN. IMMUNOL., vol. 17, 2005, pages 304 - 312, XP004979406, DOI: 10.1016/j.smim.2005.05.001
N. WATANABEY.-H. WANGH. K. LEET. ITOY.-H. WANGW. CAOY.-J. LIU: "Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus", NATURE, vol. 436, 2005, pages 1181 - 1185, XP003004232, DOI: 10.1038/nature03886
OH, YJANG, J, MOLECULES AND CELLS, vol. 42, no. 3, 2019, pages 200 - 209
R. VENTO-TORMO ET AL.: "Single-cell reconstruction of the early maternal-fetal interface in humans", NATURE, vol. 563, 2018, pages 347 - 353, XP036632378, DOI: 10.1038/s41586-018-0698-6
R. VENTO-TORMO ET AL.: "Single-cell reconstruction of the earlymaternal-fetal interface in humans", NATURE, vol. 563, 2018, pages 347 - 353, XP036632378, DOI: 10.1038/s41586-018-0698-6
RUSSALEI., MOL. CELL. BIOL., vol. 35, no. 22, November 2015 (2015-11-01), pages 3800 - 3809
SHI ET AL., NATURE REVIEWS DRUG DISCOVERY, vol. 16, 2017, pages 115 - 130

Similar Documents

Publication Publication Date Title
CA186123S (en) Battery
GB201813178D0 (en) Cell
PT3930031T (en) Battery
GB201819540D0 (en) T cell modification
PL3836300T3 (en) Battery
GB201803079D0 (en) Cell
GB202005216D0 (en) Cell
GB202007321D0 (en) T cells
ZA202003594B (en) Robot cell
GB202006820D0 (en) Cell
GB201904971D0 (en) Cell
GB201801625D0 (en) Reversible cell
HUE061671T2 (en) Secondary cell
GB202008642D0 (en) Electrohemical cell
GB201907799D0 (en) Battery cell
GB201816399D0 (en) Cell
GB201807693D0 (en) Cell
GB201915526D0 (en) Modified cell
GB201906202D0 (en) Cell
CA185441S (en) Cell culture insert
GB201805918D0 (en) Cell
GB2574854B (en) Cell selection procedures
GB201915803D0 (en) Cell production
CA190719S (en) Battery
GB201918902D0 (en) Cell differentiation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)